ALNY Alnylam Pharmaceuticals Inc.
Permanent stock page ↗Health Care · Nasdaq 100
Next earnings: not announced yet
What 33 analyst firms say about Alnylam Pharmaceuticals Inc: their latest ratings, price targets and how far the stock is from them. How it works
Analyst window: Latest analyst report within last 1 year
Analyst view · last 1Y
32 rated views · 33 analyst/firm records · 33 firms
Radar score
- Nasdaq 100 · Top Picks · 6MBelow the Radar threshold of 8051
- Nasdaq 100 · Safest consensus · 6MBelow the Radar threshold of 8031
Recent analyst activity · last 90 days
Our tracked history has 43 reports on ALNY from 28 analyst firms in the last 90 days (33 firms in the past year).
Comparing each firm's latest target with its previous one: 18 lowered it, 2 left it unchanged and 2 have their first observed target in the past year.
Ratings, latest available report against the previous one: 0 upgrades and 4 downgrades.
Latest observed target change: Truist Securities lowered its target from $315.00 (set 4 Aug 2026) to $225.00 on 2 Nov 2026.
Last 1 year. Latest opinion per identifiable analyst within the last 1 year. BUY / HOLD / SELL each count one current analyst vote; unnamed firm records are a fallback.
| Firm | Analyst | Latest rating | Report date | Latest target (USD) |
|---|---|---|---|---|
| Bank of America Securities | Tazeen Ahmad | Buy | 30 Oct 2026 | 287.00 USD |
| Barclays | Eliana Merle | Buy | 13 Oct 2026 | Conflicting reports · excluded |
| Bernstein | Jeffrey Walch | Hold | 30 Oct 2026 | 199.00 USD |
| BMO Capital Markets | David Lebowitz | Buy | 30 Oct 2026 | 290.00 USD |
| Canaccord Genuity | Whitney Ijem | Buy | 17 Aug 2026 | Conflicting reports · excluded |
| Cantor Fitzgerald | Olivia Brayer | Hold | 30 Oct 2026 | 290.00 USD |
| Chardan Capital Markets | Keay Nakae | Buy | 30 Oct 2026 | 375.00 USD |
| Citigroup | Eric Joseph | Buy | 14 Oct 2026 | 320.00 USD |
| Evercore ISI | Cory Kasimov | Buy | 4 Aug 2026 | 325.20 USD |
| Freedom Capital | Unnamed analyst | Buy | 17 Feb 2026 | — |
| Freedom Capital Markets | Ilya Zubkov | Buy | 15 Sep 2026 | Conflicting reports · excluded |
| Goldman Sachs | Salveen Richter | Buy | 30 Oct 2026 | 320.00 USD |
| Guggenheim | Debjit Chattopadhyay | Hold | 28 Oct 2026 | — |
| H.C. Wainwright | Patrick R. Trucchio | Buy | 28 Oct 2026 | 455.00 USD · 21 Sep 2026 |
| Jefferies | Faisal Khurshid | Hold | 30 Oct 2026 | 180.00 USD |
| JPMorgan | Jessica Fye | Buy | 30 Sep 2026 | 369.00 USD |
| Leerink Partners | Mani Foroohar | Hold | 15 Dec 2025 | 351.00 USD |
| Morgan Stanley | Michael Ulz | Hold | 30 Oct 2026 | 240.00 USD |
| Needham | Joseph Stringer | Buy | 29 Oct 2026 | 243.00 USD |
| Oppenheimer | Kostas Biliouris | Buy | 30 Oct 2026 | 320.00 USD |
| Piper Sandler | Edward A Tenthoff | Buy | 23 Oct 2026 | 489.00 USD |
| Raymond James | Martin Auster | Buy | 30 Oct 2026 | 315.00 USD |
| RBC Capital Markets | Luca Issi | Buy | 30 Oct 2026 | 280.00 USD |
| Redburn | Research Department | Buy | 1 Jun 2026 | 566.00 USD |
| Stifel | Paul Matteis | Hold | 29 Oct 2026 | 225.00 USD |
| TD Cowen | Ritu Baral | Buy | 30 Oct 2026 | 354.00 USD |
| Truist | Danielle Brill | Hold | 2 Nov 2026 | 225.00 USD |
| UBS | Joon Lee | Buy | 30 Oct 2026 | 329.00 USD |
| Weiss Ratings | Unnamed analyst | — | 29 Oct 2026 | — |
| Wells Fargo | Derek Archila | Hold | 30 Oct 2026 | 220.00 USD |
| William Blair | Myles R Minter | Buy | 13 Oct 2026 | — |
| Wolfe Research | Andy G Chen | Hold | 27 Feb 2026 | — |
| Data feed RESEARCH | Research Team | Hold | 23 Oct 2026 | Conflicting reports · excluded |
Partial coverage · checked 6 Nov (6 Nov 2026, 02:35 ET). Some research records could not be refreshed. Cached records retained. Prices stream live during the US session; otherwise stored prices delayed about 15 minutes. A summary of analyst opinion, not investment advice.